Fernanda Tavares-da-Silva (Fernanda Tavares Da Silva, Fernanda Tavares-Da-Silva)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Extracorporeal Membrane Oxygenation

Machine Learning

Top Venues

Advances in pharmacological and pharmaceutical sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Christophe Dessart, Fernanda Tavares-da-Silva, Lionel Van Holle, Olivia Mahaux, Jens-Ulrich Stegmann
A Model for Monitoring Spontaneously Reported Medication Errors Using the Adjuvanted Recombinant Zoster Vaccine as an Example. Advances in pharmacological and pharmaceutical sciences 2024 (2024)
Christophe Dessart, Fernanda Tavares-da-Silva, Lionel Van Holle, Olivia Mahaux, Jens-Ulrich Stegmann
A Model for Monitoring Spontaneously Reported Medication Errors Using the Adjuvanted Recombinant Zoster Vaccine as an Example. Advances in pharmacological and pharmaceutical sciences 2024 (2024)
Paola Pirrotta, Fernanda Tavares-da-Silva, Maribel Co, Nicolas Lecrenier, Caroline Hervé, Jens-Ulrich Stegmann
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine. Drug safety 44 (12) (2021)
Marta López-Fauqued, Maribel Co-van der Mee, Adriana Bastidas, Pierre Beukelaers, Alemnew F Dagnew, Juan Jose Fernandez Garcia, Anne Schuind, Fernanda Tavares-da-Silva
Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials. Drug safety 44 (7) (2021)
Fernanda Tavares-da-Silva, Olivia Mahaux, Lionel Van Holle, François Haguinet, Harry Seifert, Jens-Ulrich Stegmann
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology. Drug safety 43 (12) (2021)
Caroline Hervé, Béatrice Laupèze, Giuseppe Del Giudice, Arnaud M Didierlaurent, Fernanda Tavares-da-Silva
The how's and what's of vaccine reactogenicity. NPJ vaccines 4 (2019)